Clinical Study to evaluate the effectiveness of Linga chendooram in the management of Uthiravatha suronitham (Rheumatoid arthritis)

Phase 2

Not yet recruiting

• Conditions: Rheumatoid arthritis with rheumatoid factor, unspecified,

• Registration Number: CTRI/2023/09/057492

Brief Summary

A clinical study to evaluate the effectiveness of Linga chendooram in management of Uthiravathasronitham ie Rheumatoid arthritis 10 patients will be conducted at National institute of Siddha Tamabaram sanatorium Chennai-47 from September to November. 2023

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-05-09
• Study Start: 2023-09-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Onset of arthritis after the age of 16 years Positive for rheumatoid factor (RF) Anti.
• CCP Either an erythrocyte sedimentation rate (ESR) of greater than 30 mm/hr OR C-reactive protein level greater than 1.0 mg/dl (normal less than 0.4) Diagnosis of Uthira Vatha Suronitham, as defined by fulfilling at least more than two articular involvements Minor Morning stiffness Willing to take study medication Willing to follow diet restriction Patients giving informed consent (Signed or oral witnessed, according to local regulations) before any Protocol specific procedures.

Exclusion Criteria

Uncontrolled Diabetes Mellitus Uncontrolled Hypertension Cardiac disease Renal disease Neurological disorders Pregnancy and lactation History of alcohol or substance abuse Active infection, or chronic or persistent infection that might worsen with immunosuppressive treatment Patients who have already participated in a new drug study in the past 3 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of pain and swelling of the joints	Baseline and 12 th week

Secondary Outcome Measures

Name	Time	Method
To study the clinical laboratory parameters related to RA RA Factor CRP ESR etc	Baseline ad 12th wek

Trial Locations

Locations (1)

National Institute of Siddha; 🇮🇳 Chennai, TAMIL NADU, India

National Institute of Siddha

🇮🇳Chennai, TAMIL NADU, India

Dr Janani Syamaroopa Jnanathapaswini

Principal investigator

9447709745

jsrjtp@gmail.com